Keyphrases
Carbapenem-resistant Acinetobacter Baumannii
100%
Pandemic Response Box
100%
Drug Combination
100%
Baumannii
100%
Antimicrobial Resistance
22%
Thai Patients
11%
Murine Wound Model
11%
Lose Efficacy
11%
Brilacidin
11%
Extensive Drug Resistance
11%
Eravacycline
11%
Novel Antimicrobials
11%
Antibiotics
11%
Chemical Scaffolds
11%
Biofilm Formation
11%
Acinetobacter Baumannii (A. baumannii)
11%
Malaria
11%
Human Health
11%
Infected Wound
11%
Effective Antibiotics
11%
Synergistic Drug Combination
11%
Acinetobacter
11%
Inhibitory Effect
11%
Triclosan
11%
Pathogen Box
11%
Therapeutic Development
11%
Hospital-acquired Infection
11%
In Vitro Growth
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
100%
Combination Drug
100%
Antiinfective Agent
50%
Antibiotics
50%
Wound Infection
50%
Eravacycline
25%
Brilacidin
25%
Murine
25%
Infection
25%
Drug Resistance
25%
Acinetobacter
25%
Infectious Agent
25%
Antimicrobial Resistance
25%
Triclosan
25%
Hospital Infection
25%
Immunology and Microbiology
Acinetobacter Baumannii
100%
Infectious Agent
50%
Biofilm
50%
Antimicrobial Resistance
50%
Murine
50%
Acinetobacter
50%
Bactericidal Activity
50%
Drug Resistance
50%